{
    "code": "52026148",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026148",
    "time": "2019-04-05 03:57:38",
    "許可證字號": "衛部藥輸字第026148號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/09\/23",
    "發證日期": "102\/09\/23",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202614808",
    "中文品名": "米達紗賓",
    "英文品名": "Mirtazapine",
    "適應症": "鬱症",
    "劑型": "040（粉）",
    "包裝": "0.5公斤以上裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620109C968  新雙隆生技股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F200714200  NEULAND LABORATORIES LIMITED",
        "製造廠廠址": "Unit-Ⅰ, SY.NO.347,473,474&amp;490\/2 BONTHAPALLY VILLAGE, VEERABHADRASWAMY TEMPLE ROAD, GUMMADIDALA MANDAL, SANGAREDDY DISTRICT - 502313, TELANGANA STATE, INDIA",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "20131014092611703-102-10-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026148&Seq=001&Type=9"
        }
    ]
}